Extended-release ranolazine: critical evaluation of its use in stable angina

References

• AslamSGrayDRanolazine (Ranexa) in the treatment of chronic stable anginaAdv Ther201027419320120449698
   PubMed Web of Science ®Google Scholar
• TrujilloTCDobeshPPTraditional management of chronic stable anginaPharmacotherapy200727121677169218041888
   PubMed Web of Science ®Google Scholar
• RogerVLGoASLloyd-JonesDMHeart disease and stroke statistics – 2011 update: A report from the American Heart AssociationCirculation20111234e18e20921160056
   PubMed Web of Science ®Google Scholar
• VadnaisDSWengerNKEmerging clinical role of ranolazine in the management of anginaTher Clin Risk Manag2010651753021063462
   PubMed Web of Science ®Google Scholar
• NortonCGeorgiopoulouVKalogeropoulosAButlerJChronic stable angina: Pathophysiology and innovations in treatmentJ Cardiovasc Med (Hagerstown)201112321821921252693
   PubMed Web of Science ®Google Scholar
• SmithSCJrAllenJBlairSNAHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood InstituteCirculation2006113192363237216702489
   PubMed Web of Science ®Google Scholar
• MelloniCNewbyLKMetabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) studyExpert Rev Cardiovasc Ther20086191618095903
   PubMedGoogle Scholar
• MorrowDASciricaBMKarwatowska-ProkopczukESkeneAMcCabeCHBraunwaldEEvaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trialAm Heart J20061516e1181e1189
   Web of Science ®Google Scholar
• StonePHGratsianskyNABlokhinAHuangIZMengLAntianginal efficacy of ranolazine when added to treatment with amlodipine: The ERICA (Efficacy of Ranolazine in Chronic Angina) trialJ Am Coll Cardiol200648356657516875985
   PubMed Web of Science ®Google Scholar
• FrakerTDJrFihnSDGibbonsRJ2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable anginaJ Am Coll Cardiol200750232264227418061078
   PubMed Web of Science ®Google Scholar
• Coronary angioplasty versus medical therapy for angina: The second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participantsLancet199735090764614689274581
   PubMed Web of Science ®Google Scholar
• BodenWEO’RourkeRATeoKKOptimal medical therapy with or without PCI for stable coronary diseaseN Engl J Med2007356151503151617387127
   PubMed Web of Science ®Google Scholar
• NewbyLKPetersonEDDoes ranolazine have a place in the treatment of acute coronary syndromes?JAMA2007297161823182517456825
   PubMed Web of Science ®Google Scholar
• MorrowDASciricaBMKarwatowska-ProkopczukEEffects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: The MERLIN-TIMI 36 randomized trialJAMA2007297161775178317456819
   PubMed Web of Science ®Google Scholar
• DobeshPPTrujilloTCRanolazine: A new option in the management of chronic stable anginaPharmacotherapy200727121659167618041887
   PubMed Web of Science ®Google Scholar
• LetienneRVieBPuechAVieuSLe GrandBJohnGWEvidence that ranolazine behaves as a weak beta1- and beta2-adrenoceptor antagonist in the cat cardiovascular systemNaunyn Schmiedebergs Arch Pharmacol2001363446447111330341
   PubMed Web of Science ®Google Scholar
• AllelyMCBrownCMKennyBAKilpatrickATMartinASpeddingMModulation of alpha 1-adrenoceptors in rat left ventricle by ischaemia and acyl carnitines: Protection by ranolazineJ Cardiovasc Pharmacol19932168698737687710
   PubMed Web of Science ®Google Scholar
• ZhaoGWalshEShryockJCAntiadrenergic and hemodynamic effects of ranolazine in conscious dogsJ Cardiovasc Pharmacol201157663964721633249
   PubMed Web of Science ®Google Scholar
• ChaitmanBRSkettinoSLParkerJOAnti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaJ Am Coll Cardiol20044381375138215093870
   PubMed Web of Science ®Google Scholar
• EstacionMWaxmanSGDib-HajjSDEffects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitabilityMol Pain201063520529343
   PubMed Web of Science ®Google Scholar
• SiddiquiMAKeamSJRanolazine: A review of its use in chronic stable angina pectorisDrugs200666569371016620147
   PubMed Web of Science ®Google Scholar
• ChaitmanBRPepineCJParkerJOEffects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: A randomized controlled trialJAMA2004291330931614734593
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration Available from: http://www.fda.gov/ohrms/dockets/ac/03/briefing/4012B2_01_Action%20Letter.pdf. Accessed April 4, 2007.
   Google Scholar
• PenmanADEadieJHerronWJReillyMARushWRLiuYThe characterization of the metabolites of ranolazine in man by liquid chromatography mass spectrometryRapid Commun Mass Spectrom1995914141814308534891
   PubMed Web of Science ®Google Scholar
• HerronWJEadieJPenmanADEstimation of ranolazine and eleven phase I metabolites in human plasma by liquid chromatography-atmospheric pressure chemical ionisation mass spectrometry with selected-ion monitoringJ Chromatogr A1995712155608556155
   PubMed Web of Science ®Google Scholar
• JerlingMAbdallahHEffect of renal impairment on multiple-dose pharmacokinetics of extended-release ranolazineClin Pharmacol Ther200578328829716153399
   PubMed Web of Science ®Google Scholar
• ArnoldSVMorrowDALeiYEconomic impact of angina after an acute coronary syndrome: Insights from the MERLIN-TIMI 36 trialCirc Cardiovasc Qual Outcomes20092434435320031860
   PubMed Web of Science ®Google Scholar
• ArnoldSVMorrowDAWangKEffects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: Results from the MERLIN-TIMI 36 randomized trialCirc Cardiovasc Qual Outcomes20081210711520031797
   PubMed Web of Science ®Google Scholar